In agreement with the results from the cell-cycle analysis, we found that the protein expression of the negative cell-cycle regulator P21 was markedly increased in breast cancer cells after ZLM-7 treatment, which was accompanied with decreased expressions of cyclin D1, CDK2 and CDK6 (Figure 3B). This evidence concerns the gene CDK6 and breast cancer.